These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1901638)

  • 21. [Size reduction of uterine myomas with monthly administered leuprolide acetate].
    Cheviakoff S; Bocaz JA; Martínez L; Romero C
    Rev Chil Obstet Ginecol; 1994; 59(6):416-20; discussion 420-1. PubMed ID: 7569160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.
    Friedman AJ
    Fertil Steril; 1989 Jul; 52(1):152-4. PubMed ID: 2501108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leuprolide acetate treatment and myoma arterial size.
    Rutgers JL; Spong CY; Sinow R; Heiner J
    Obstet Gynecol; 1995 Sep; 86(3):386-8. PubMed ID: 7651647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The concentrations of collagen-associated amino acids are higher in GnRH agonist-treated uterine myomas.
    Rein MS; Barbieri RL; Welch W; Gleason RE; Caulfield JP; Friedman AJ
    Obstet Gynecol; 1993 Dec; 82(6):901-5. PubMed ID: 8233262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Morris EP; Rymer J; Robinson J; Fogelman I
    Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist.
    Rein MS; Friedman AJ; Heffner LJ
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1554-8. PubMed ID: 2112150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
    Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
    Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
    Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H
    Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
    Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M
    Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short-term treatment with leuprolide acetate depot before surgical intervention for uterine leiomyomatosis].
    D'Anna R; Palmara V; Lo Re C; Scilipoti A; Leonardi I
    Minerva Ginecol; 1994 Jun; 46(6):343-6. PubMed ID: 7936386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
    Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study.
    Reinsch RC; Murphy AA; Morales AJ; Yen SS
    Am J Obstet Gynecol; 1994 Jun; 170(6):1623-7; discussion 1627-8. PubMed ID: 8203418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy.
    Cohen D; Mazur MT; Jozefczyk MA; Badawy SZ
    J Reprod Med; 1994 May; 39(5):377-80. PubMed ID: 7520497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
    Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
    Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group.
    Stovall TG; Muneyyirci-Delale O; Summitt RL; Scialli AR
    Obstet Gynecol; 1995 Jul; 86(1):65-71. PubMed ID: 7784025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological changes in leiomyomata treated with leuprolide acetate.
    Upadhyaya NB; Doody MC; Googe PB
    Fertil Steril; 1990 Nov; 54(5):811-4. PubMed ID: 2121550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of adenomyosis with long-term GnRH analogues: a case report.
    Grow DR; Filer RB
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):538-9. PubMed ID: 1908069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.